Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03685591
Title PF-06952229 Treatment in Adult Patients With Advanced Solid Tumors
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Pfizer

prostate cancer

Advanced Solid Tumor

Her2-receptor negative breast cancer



Enzalutamide + PF-06952229

Letrozole + Palbociclib + PF-06952229

Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.